New longer-acting molecules and home monitoring will soon help relieve the increasing burden of age-related macular degeneration and diabetes-related ocular pathologies, both in patients and on public health delivery, according to one specialist.
“The number of patients who suffer from AMD is significantly on the increase due to the aging of the population. We are going to deal with more than 1 billion patients in the next decade, a big issue of public health,” Anat Loewenstein, MD, MHA, said in an interview with Ocular Surgery News.
The first priority is (Read more...)
Uncategorized